Select to view the solutions available in your location.
Learn more about our innovative products and services that help detect cancer earlier and power smarter treatment decisions.
Exact Sciences is working to eradicate cancer by delivering a portfolio that gives providers the information they need to better serve their patients across the cancer care continuum — starting with familial risk.
Find out how our scientific rigor, quality standards, and development of future tests make us a leader in cancer testing and treatment guidance.
Exact Sciences expects the test to be available in 2025, pending approval.
Learn all about Exact Sciences, including our purpose, the people who drive it, our history, and the impact we’ve made.
The company’s commitment to community involvement keeps paying off when employees get back from giving back.
Explore stories, news, and events that highlight our innovation, technology, and people fighting cancer on all fronts.
Aspirin's role in cancer prevention and treatment has long been a popular topic of medical studies.
Most recently, a study published in the Journal of the National Cancer Institute showed women who take a small dose of aspirin had up to 20% decreased risk of developing ovarian cancer, again reigniting the discussion around aspirin's cancer-fighting potential.
Previous research focused specifically on aspirin's effect on colon cancer risk produced mixed, but mostly positive results.
For example, an a July 2013 study, researchers found women who took an aspirin every other day for 18 years experienced a drop in colon cancer risk of about 20%. A 2012 British study produced similar findings.
But why might aspirin have this effect on colon cancer risk?
Later in 2013, researchers attempted to answer that question, explaining that "interaction of the body's immune system with the effect of aspirin on platelets (cell fragments in the blood that are involved in clotting)" might cause the decreased risk. Aspirin's capacity as an anti-inflammatory drug may also help to explain its cancer-fighting potential.
However, no matter how strong the case for aspirin use might be, many physicians remain wary of recommending widespread use because of the side effects it produces, including (among others) gastrointestinal bleeding and ulcers. Stanford associate professor of medicine Dr. Randall Stafford explained these reservations to The San Francisco Chronicle:
"The ideal candidate for aspirin is the person who has more than average risk of developing stroke or heart attack or cancer," Stafford said. "If I'm an individual at very low risk of developing any one of those three outcomes, it may well be aspirin is going to cause more harm than benefit."
As always, make sure your doctor helps you understand the risks and benefits of any medical decision before making it.
For more updates from the Exact Sciences team, sign up to get our enewsletter.
Creative Commons image via cpradi